#What led to Wise Group's application being denied?
Wise Group, known previously as TransferWise, faced a setback when the Office of the Comptroller of the Currency rejected its application for a national trust bank charter on July 23, 2026. This was not entirely unexpected, as previously submitted applications can undergo rigorous scrutiny. The fintech firm announced plans to revise and resubmit its application under the GENIUS Act framework, a federal law designed to regulate stablecoins, which was enacted shortly before Wise’s initial filing last year.
Wise’s charter application, submitted in June 2025, aimed to gain direct access to US payment networks, bypassing the complexities of state regulation. Without a national charter, Wise cannot access these resources directly.
#Why is the GENIUS Act important for Wise?
The GENIUS Act, which became law on July 18, 2025, established a federal regulatory framework for stablecoins. This law presents new opportunities by allowing uninsured national trust banks to issue stablecoins, indicating a strategic shift for Wise as it seeks to redefine its approach within the US market. This demonstrates that Wise is aligning its future strategies with the evolving stablecoin landscape, signaling to investors its commitment to growth in this area.
A sharper way to see the markets in just 5 minutes.
Same news, different lens. We cut through the noise and hand you the overlooked ideas and the deeper read the crowd misses. Join 38,000+ investors seeing the markets differently.
#How does compliance affect Wise's future?
The denial was primarily attributed to compliance issues related to anti-money laundering practices exposed in a multi-state consent order issued in July 2025. Such orders are legally binding, pressuring Wise to enhance its compliance protocols to meet regulatory standards expected of nationally chartered institutions.
Wise’s leadership remains optimistic, indicating that ongoing improvements will align its compliance efforts with OCC expectations. Resolving the AML consent order is crucial for Wise’s reapplication, as it aims for a stronger compliance position that satisfies regulatory bodies.
#What does this mean for Wise’s investors?
The decline in Wise's share price, which dropped by as much as 11% post-announcement, illustrates a shift in investor expectations regarding the company's growth timeline in the US market. A national charter would have streamlined operations and potentially unlocked new revenue opportunities through stablecoin issuance.
Investors should monitor two key developments: the timing of Wise’s new application under the GENIUS Act and the resolution of AML compliance issues before the reapplication. Addressing these compliance hurdles is vital to avoid facing the same situation once again.